Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-02

Clinical Trial Update: Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

View source ↗

Summary

A completed long-term Special Drug Use Investigation evaluating paroxetine (Paxil) for social anxiety disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PAXIL (paroxetine hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Status: COMPLETED